Most recently, Mr Leest was Arterial Remodeling Technologies’s (ART’s) COO since March 2008. Prior to joining ART, he was director of R&D and regulatory affairs since May 2003 at Minvasys. Prior to joining ART, he was director of R&D and regulatory affairs since May 2003 at Minvasys.
Thierry Chignon, director of ART, said: “Because of ART’s approach of achieving temporary stenting of a traumatized angioplasty site, the company expects to benefit greatly from Machiel’s proven understanding of the development, regulatory, clinical, manufacturing and market dynamics of the bioresorbable stent sector.”